Student
News
Drug company accused of breaking regulations
BMJ 2003; 326 doi: https://doi.org/10.1136/sbmj.0306180c (Published 01 June 2003) Cite this as: BMJ 2003;326:0306180c
- Fabian Waechter1
- 1BMJ
The Drug and Therapeutics Bulletin has accused the drug company Novartis of breaching advertising regulations in its advertisement for pimecrolimus, a new cream for treating dermatitis (2003;41(5):33-6).
The bulletin was concerned that while the licence …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.